Vanguard Capital Management
EVH icon

Vanguard Capital Management’s Evolent Health EVH Stock Holding History

Vanguard Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Sell
4,787,994
-79,409
-2% -$304K ﹤0.01% 2305
2026
Q1 		$11.1M Buy
+4,867,403
New +$15.4M ﹤0.01% 2679

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's EVH Position: Q2 2026 in Review

Vanguard Capital Management reduced its Evolent Health (EVH) stake by 1.6% in Q2 2026, selling an estimated $304K and leaving 4,787,994 shares worth $26M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Vanguard Capital Management first reported a position in EVH in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Vanguard Capital Management held 4,787,994 shares of Evolent Health worth $26M as of Q2 2026.
  • Vanguard Capital Management sold 79,409 Evolent Health shares in Q2 2026, an estimated $304K.
  • Evolent Health made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2305 holding.
  • Vanguard Capital Management first reported a position in Evolent Health in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.